HC Wainwright reaffirmed their buy rating on shares of Precigen (NASDAQ:PGEN – Free Report) in a report issued on Wednesday, Benzinga reports. HC Wainwright currently has a $6.00 price target on the biotechnology company’s stock. HC Wainwright also issued estimates for Precigen’s Q1 2024 earnings at ($0.09) EPS, Q2 2024 earnings at ($0.09) EPS, Q3 […]
Precigen (NASDAQ:PGEN – Get Free Report) was upgraded by research analysts at StockNews.com to a “sell” rating in a research note issued on Tuesday. Precigen Stock Performance NASDAQ PGEN opened at $1.38 on Tuesday. The company’s fifty day moving average is $1.30 and its two-hundred day moving average is $1.32. Precigen has a 52-week low […]
Precigen (NASDAQ:PGEN – Get Free Report) was upgraded by stock analysts at StockNews.com to a “sell” rating in a research report issued on Tuesday. Precigen Price Performance Shares of PGEN opened at $1.38 on Tuesday. The firm has a fifty day simple moving average of $1.30 and a two-hundred day simple moving average of $1.32. […]
Magnolia Capital Advisors LLC purchased a new stake in shares of Precigen, Inc. (NASDAQ:PGEN – Free Report) during the 3rd quarter, according to the company in its most recent filing with the SEC. The fund purchased 39,997 shares of the biotechnology company’s stock, valued at approximately $57,000. Other large investors have also recently bought and […]
Magnolia Capital Advisors LLC purchased a new position in shares of Precigen, Inc. (NASDAQ:PGEN – Free Report) in the third quarter, Holdings Channel.com reports. The institutional investor purchased 39,997 shares of the biotechnology company’s stock, valued at approximately $57,000. Other hedge funds also recently added to or reduced their stakes in the company. Emfo LLC […]